Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from citrus
Reexamination Certificate
2007-04-10
2007-04-10
Tate, Christopher (Department: 1657)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from citrus
C424S725000, C424S777000
Reexamination Certificate
active
10088664
ABSTRACT:
Compositions and methods of inhibiting tumor cell growth and treating and preventing cancer are provided based on administration of an orange peel extract either alone or in combination with other phytochemicals.
REFERENCES:
patent: 3867541 (1975-02-01), Robbins
patent: 3903266 (1975-09-01), Robbins
patent: 5041425 (1991-08-01), Hasegawa et al.
patent: 5580545 (1996-12-01), Washino et al.
patent: 5830738 (1998-11-01), Thomas et al.
patent: 5859293 (1999-01-01), Bailey et al.
patent: 6184246 (2001-02-01), Manthey et al.
patent: 6221357 (2001-04-01), Bok et al.
patent: 6239114 (2001-05-01), Guthrie et al.
patent: 6251400 (2001-06-01), Guthrie et al.
patent: 6706256 (2004-03-01), Lawlor
patent: 1030078 (1989-01-01), None
patent: 1049340 (1991-02-01), None
patent: 1069200 (1993-02-01), None
patent: 1094957 (1994-11-01), None
patent: 1100322 (1995-03-01), None
patent: 1105853 (1995-08-01), None
patent: 1108554 (1995-09-01), None
patent: 1139007 (1997-01-01), None
patent: 1145804 (1997-03-01), None
patent: 1170592 (1998-01-01), None
patent: 1191746 (1998-03-01), None
patent: 1279905 (2001-01-01), None
patent: 1301507 (2001-07-01), None
patent: 1071576 (2001-09-01), None
patent: 39 22 666 (1989-07-01), None
patent: 60-199817 (1985-10-01), None
patent: 9-295932 (1997-11-01), None
patent: 2000-83654 (1998-09-01), None
patent: 3010210 (1999-12-01), None
patent: 2000-80035 (2000-03-01), None
patent: 2000083654 (2000-03-01), None
patent: 2004-137218 (2004-05-01), None
patent: WO 1999/15167 (1999-04-01), None
patent: WO 1999/52380 (1999-10-01), None
patent: WO 1999/62358 (1999-12-01), None
patent: WO 2000/07607 (2000-02-01), None
patent: WO 2000/32062 (2000-06-01), None
patent: WO 2000/64282 (2000-11-01), None
patent: WO 2000/76492 (2000-12-01), None
patent: WO 2001/51043 (2001-07-01), None
patent: WO 2001/70029 (2001-09-01), None
Nagy et al. Citrus Science and Technology, 1977, AVI, Westport, vol. 1, pp. 416-417.
Malterud et al. J. Agric. Food Chem., 2000, 48, pp. 5576-5580.
Peirce, A. The American Pharmaceutical Association Practical Guide to Natural Medicines, 1999, Stonesong Press, Inc., pp. 563-566.
Madis Botanicals, Inc., Resverapure™ Resveratrol PE 8%, Product Code 04544, p. 2, Lines 6-7 and 15-31, 1997.
Castleman, M., The Healing Herbs, The Ultimate Guide to the Curative Power of Nature's Medicines, 1991, Rodale Press, Emmaus, PA. p. 349.
Plant Specimen (http://www.cresentbloom.com/Specimen/Cl /default.htm.
Xu et al. 1993. Effects of fruit juicesyprocessed vegetable juice, orange peel and green tea on endogenous formation of N-nitrosoproline in subjects from a high-risk area for gastric cancer in Moping County,china. Eur J of Cancer Prevention, vol. 2: 327-33.
Kuo S. M., (1997) “Dietary flavonoid and cancer prevention: evidence and potential mechanism”, Critical Reviews™ in Oncogenesis, vol. 8, 1, pp. 47-49.
Lamartiniere et al., (1995). “Neonatal genistein chemoprevents mammary cancer”, Proc. Soc. Exp. Biol. Med., vol. 208, pp. 120-123.
Mak et al., (1996). “Isolation of anti-leukemia compounds from citrus reticulata”, Life Sciences, vol. 58, 15, pp. 1269-1276.
Miyazawa et al., (1999). “Antimutagenic activity of polymethoxyflavonoids from citrus aurantium”. J. Agric. Food Chem.. vol. 47, pp. 5239-5244.
Murakami et al., (2000). “Suppressive effects of citrus fruits on free radical generation and nobiletin, an anti-inflammatory polymethoxyflavonoid”. Biofactors. vol. 12, 1-4, p. 6.
Robbins R.C., (1988). “Flavones in citrus exhibit antiadhesive action on platelets”, Florida Agricultural Experiment Station Journal, Series No. 9146, pp. 418-421.
Rogers et al., (1998), “Black tea and mammary gland carcinogenesis by 7,12-dimethylbenz[a]anthracene in rats fed control or high fat diets”, Carcinogenesis, vol. 19, 7, pp. 1269-1273.
Singletary et al., (1996), “Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation”, Cancer Letters, vol. 104, pp. 43-48.
Singletary et al., (1991), “Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and of in vivo formation of mammary DMBA-DNA adducts by rosemary extract”, Cancer Letters, vol. 60, pp. 169-175.
Stoner et al., (1995). “Polyphenols as cancer chemopreventive agents”, Journal of Cellular Biochemistry, Supplement, vol. 22, pp. 169-180.
Takase et al., (1994), “Pharmacological profile of gastric mucosal protiection by marmin and nobiletin from a traditional herbal medicine,Aurantii Fructus Immaturus”, Jpn. J. Pharmacol., vol. 66, pp. 139-147.
Telang et al., (1990), “Neoplastic transformation of mouse mammary epithelial cells by deregulatedmycexpression”, Cell Regulation, vol. 1, pp. 863-872.
Tokuda et al., (1986). “Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate”, Cancer Letters, vol. 33, pp. 279-285.
Verhoeven et al., (1996), “Epidemiological studies on brassica vegetables and cancer risk”, Cancer Epidemiology, Biomarkers and Prevention, vol. 5, pp. 733-748.
Weisburger et al., (1998), “Effect of black tea on azoxymethane-induced colon cancer”, Carcinogenesis, vol. 19, 1, pp. 229-232.
Yang et al., (1997), “Black tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice”. Carcinogenesis, vol. 18, 12, pp. 2361-2365.
“Colon cancer prevention and citrus flavonoid,”Nutrition Research Newsletter17(7-8) (1998).
“Fruit with a pun,”Natural Healthpp. 116-119,187(Jul.-Aug. 1998).
“Fruitful findings on cancer,”Tufts University Diet&Nutrition Letterp. 6 (Aug. 1996).
Attaway, “Citrus juice flavonoids with anti-cancer properties,”Abstracts of Papers of the American Chemical Society,, 204:P184-AGFD (1992) [abstract].
Boterberg et al., “Inhibition of the tamoxifen by the citrus favonoid tangeretin: an NK cell mediated effect?”Acta Clinica Belgica54(2):109 (1999) [abstract].
Bracke et al., “Citrus flavonoid effect on tumor invasion and metastasis the citrus flavonoid tangeretin may inhibit the processes that shorten the life expectancy of tumor-bearing patients,”Food Technology, Institute of Food Technologists, Chicago, US, 48(11):121-124 (1994).
Bracke et al., “Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer,”J. National CancerInstitute 91(4):354-359 (1999).
Bracke et al., “The citrus flavonoid tangeretin enhances cell-cell adhesion and inhibits invasion of human MCF-7/6 breast carcinoma cells,”Abstracts of Papers American Chemical Society208(1-2): pAGFD 81 [abstract] (1994).
Bracke et al., “The flavonoid tangeretin inhibits invasion of MO4mouse cells into embryonic chick heartin vitro,”Clin. Expl. Metastasis7(3):283-300 (1989).
Bracke et al., “Tangeretin affects human mammary cell interactions,”Abstracts of Papers American Chemical Society219 (1-2): pAGFD 184 (2000).
Breinholt et al., “Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat,”Xenobiotica29(12):1227-1240 (1999).
Carroll et al., “Anticancer properties of flavonoids, with emphasis on citrus flavonoids,”Flavonoids in Health and Disease, Rice-Evans CA, Parker L, eds., Marcel Dekker Inc, NY, Chapter 19, pp. 437-446 (1998).
Chaumontet et al., “Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells,”Carcinogenesis15(10):2325-2330 (1994).
Chaumontet et al., “Flavonoids (apigenin, tangeretin) conteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells,”Cancer Letters114:207-210 (1997).
Chaumontet et al., “Lack of tumor-promoting effects of flavonoids:
Boyd Charles
Chen Kuang Yu
Csiszar Katalin
Ghai Geetha
Ho Chi-Tang
Rutgers The State University of New Jersey
Srivastava Kailash C.
Tate Christopher
LandOfFree
Extracts of orange peel for prevention and treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extracts of orange peel for prevention and treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extracts of orange peel for prevention and treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3727374